A phase II study of high-dose epirubicin in ovarian cancer patients previously treated with cisplatin. EORTC Gynecological Cancer Cooperative Group (Q73093118)
Jump to navigation
Jump to search
scientific article published on 01 August 2000
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase II study of high-dose epirubicin in ovarian cancer patients previously treated with cisplatin. EORTC Gynecological Cancer Cooperative Group |
scientific article published on 01 August 2000 |
Statements
A phase II study of high-dose epirubicin in ovarian cancer patients previously treated with cisplatin. EORTC Gynecological Cancer Cooperative Group (English)
J B Vermorken
A Kobierska
B Chevallier
F Zanaboni
A Pawinski